Development of technology over the past couple of decades has led to societal and cultural development which in turn has resulted in awareness of issues such as the importance of women’s health. With vast improvements taking place in this field, obstetrics and gynecology equipment has experienced major changes.
According to a global statistics report on medical devices, the global surgical instruments market has witnessed a drastic growth spurt in the past 8 years. In 2010, global sales of surgical instruments reached 12 billion USD, 12.9 billion USD in 2011 and 18.6 billion USD in 2014.
With economic development and the ongoing medical reform, people are becoming more and more concerned about their health care and the diagnostic equipment market in China is growing at a compound annual rate of about 10%.
What’s the import and export situation of medical dressing in China? And what are the prospects of this industry? Today, pharmaceutical and medical devices online platform, Ddu, brings you the breakdown with our Medical Dressing Market Analysis Report.
With the rapid development of modern computer and signal integration technology, construction of digitalization in medical imaging devices has become a new trend. CR / DR, multi-slice spiral CT, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) have been applied in clinical practices and play an increasingly important role.
Malaysia represents one of the most vigorous and vibrant medical device markets in Southeast Asia, presenting opportunities for U.S. exporters of medical technology to expand their sales into rising economies. Increasing patient access to healthcare will remain in the focus of the Government of Malaysia for the next five years, to include upgrading facilities and equipment, and expanding delivery systems.
It is a common problem that concerned us. As a global pharmaceuticals and medical devices B2B online platform, Ddu invited Sherlock Chen, a senior biotech practitioner, to talk about how to develop the Indonesian market.
As the most potential market in china, Hemodialysis market appears a large revenue space. With the opening of private hemodialysis services, private economy in the hemodialysis industry is about to take a ”Golden era”.
The USFDA said that it has achieved a year early the target set for 2017, to take action on 90% of the applications pending prior to the start of the Generic Drug User Fee Amendment Act (GDUFA) of 2012.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.